Stevens will step down from the leadership role officially on 31 July
News
Government injects £37m into genomics and data-driven initiatives
Health Secretary reveals government’s plans for UK life sciences ‘transformation’
Calling all pharma marketers
The 2021 Marketer of the Year competition is well underway for entries and is looking for the best and brightest to join the ranks.
First UK-based clinical trial focused viral vector manufacturer announces launch
ViroCell Biologics will meet the growing demand for viral vectors in clinical trials
Triple combo cystic fibrosis therapy Kaftrio scores EU label expansion
Extension means the ‘majority’ of people aged 12 years and older with CF in Europe can now access therapy
UK-based CRO Charnwood Molecular reveals plans for ‘significant’ expansion in 2021
Company will become sole occupier of laboratory facility in Loughborough
Daiichi Sankyo’s cholesterol-lowering drugs recommended for NHS use
Nilemdo and Nustendi recommended for around 70,000 eligible adults in England with high cholesterol
RPS makes new recommendations for pharmacist independent prescribers
RPS wants to see increased use of pharmacist independent prescribers in the UK
Oxford Immunotec’s COVID-19 test to be used in ‘mix and match’ UK vaccine trial
Test will be used for T cell testing in study, which is evaluating different combinations of COVID-19 vaccines
NICE updates guideline on atrial fibrillation
Updated clinical guideline on the diagnosis and management of AF addresses several new areas
Over a quarter of UK adults have received both COVID-19 vaccine doses
UK government has also offered a first vaccine dose to all individuals in cohorts one to nine
EMA PRIME status granted for Vertex, CRISPR Therapeutics’ gene therapy CTX001
CRISPR/Cas9 gene-edited therapy is being investigated in transfusion-dependent beta thalassemia
UK cancer centre to offer breast cancer treatment at home
The Christie NHS Foundation Trust will offer the breast cancer treatment Phesgo to patients in their own homes
Chiesi’s Raxone recommended for use within NHS Wales
Medicine recommended for the treatment of visual impairment in Leber’s Hereditary Optic Neuropathy
Tagrisso moves closer towards EU approval for early-stage lung cancer
Therapy wins a positive CHMP opinion for the adjuvant treatment of early-stage EGFR-mutated NSCLC
